NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Global Innovations (International Cooperation

Bioengineering, Free Full-Text

Salmonella Typhimurium expressing chromosomally integrated

Emerging concepts in the science of vaccine adjuvants

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Mucosal vaccine delivery: Current state and a pediatric

PDF) Vaccines Against COVID-19

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Stages in COVID-19 vaccine development: The Nemesis, the Hubris